Abstract
Diabetes Technology & TherapeuticsVol. 4, No. 1 EditorialDiabetes Technology & Therapeutics Evolves, Along with Our Knowledge About Alternate Site TestingDavid C. KlonoffDavid C. KlonoffSearch for more papers by this authorPublished Online:5 Jul 2004https://doi.org/10.1089/15209150252924021AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Diabetes Technology & Therapeutics Evolves, Along with Our Knowledge About Alternate Site Testing." , 4(1), pp. 1–2FiguresReferencesRelatedDetailsCited byClosed-loop insulin delivery: from bench to clinical practice22 February 2011 | Nature Reviews Endocrinology, Vol. 7, No. 7Microfluidic perifusion and imaging device for multi-parametric islet function assessment19 March 2010 | Biomedical Microdevices, Vol. 12, No. 3 Volume 4Issue 1Feb 2002 To cite this article:David C. Klonoff.Diabetes Technology & Therapeutics Evolves, Along with Our Knowledge About Alternate Site Testing.Diabetes Technology & Therapeutics.Feb 2002.1-2.http://doi.org/10.1089/15209150252924021Published in Volume: 4 Issue 1: July 5, 2004PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
